Oklahoma Blood Institute is located in Oklahoma City, OK. The organization was established in 1977. According to its NTEE Classification (E61) the organization is classified as: Blood Banks, under the broad grouping of Health Care and related organizations. As of 03/2023, Oklahoma Blood Institute employed 1,356 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Oklahoma Blood Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 03/2021, Oklahoma Blood Institute generated $144.9m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 7.4% each year. All expenses for the organization totaled $123.8m during the year ending 03/2021. While expenses have increased by 5.5% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Oklahoma Blood Institute has awarded 23 individual grants totaling $4,815,644. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO BE THE DONOR TO PATIENT LIFELINES BY MEETING BLOOD TRANSFUSION AND HEALTH CARE NEEDS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SERVICE FEES FOR BLOOD PRODUCTS: AS THE SIXTH-LARGEST BLOOD CENTER IN THE U.S, OBI COLLECTS, TESTS, PROCESSES, AND DISTRIBUTES MORE THAN 450,000 LIFE-SAVING BLOOD PRODUCTS ANNUALLY IN 16 BLOOD DONATION CENTERS ACROSS OKLAHOMA, ARKANSAS, AND TEXAS. OUR COMPLEX TECHNOLOGICAL INFRASTRUCTURE AND RARE MEDICAL EXPERTISE ALLOW OBI TO PROVIDE SAFE AND ADEQUATE BLOOD TO PATIENTS AT MORE THAN 230 AREA HOSPITALS, MEDICAL FACILITIES, AND AIR AMBULANCES ACROSS ALL THREE STATES. OUR RIGOROUS SAFETY MEASURES AND THE TIRELESS EFFORTS OF OUR MEDICAL LABORATORY STAFF ENSURE THAT THE DONATED BLOOD IS SAFE AND AVAILABLE TO SAVE LIVES.
OTHER PROGRAM SERVICES: THESE OTHER PROGRAM SERVICES ARE BLOOD PRODUCT DERIVATIVES. DERIVATIVES ARE A PRODUCT MANUFACTURED FROM A RAW MATERIAL BYPRODUCT OF BLOOD COLLECTION. OBI COLLECTS THIS MATERIAL, WHICH IS UNUSABLE FOR BLOOD TRANSFUSION, AND DISTRIBUTES THIS BYPRODUCT TO PLASMA MANUFACTURERS WHICH, IN TURN, USE IT IN THE PRODUCTION OF A BIOLOGICAL DRUG. REVENUE FOR THIS PROGRAM IS $370,493 WITH OFFSETTING EXPENSES TOTALING $297,849. THE CELL THERAPY PROGRAM INVOLVES COLLECTIONS OF STEM CELLS AND CORD BLOOD FROM PATIENTS, TESTING, AND MANUFACTURING THE PRODUCTS FOR PATIENT USE. REVENUE FOR THIS PROGRAM IS $578,892 WITH OFFSETTING EXPENSES TOTALING $840,217. OBI MANAGES THE LIFE-SAVING BLOOD DONATIONS OF MORE THAN 200,000 PEOPLE IN THE REGION EACH YEAR. THESE UNITS OF BLOOD ARE EVENTUALLY DELIVERED TO PATIENTS ACROSS THE REGION, BUT NOT BEFORE UNDERGOING AN IMMENSE AMOUNT OF FDA-REGULATED PROCESSING AND TESTING FOR DONOR AND BLOOD RECIPIENT SAFETY. VOLUNTEER BLOOD DONORS GIVE WHAT CAN'T BE CREATED AND PROVIDED BY ANY OTHER MEANS. OBI RECRUITS DONORS AND PROVIDES SKILLED MEDICAL STAFF, TECHNOLOGY, AND FACILITIES TO COLLECT BLOOD FROM DONORS. LAB PROFESSIONALS UNDER THE MEDICAL SUPERVISION OF PHYSICIANS PREPARE THE BLOOD FOR TRANSFUSION AND ADMINISTER MULTIPLE SAFETY TESTS. ALL MUST BE DONE WITH UTMOST URGENCY AND AROUND THE CLOCK SINCE BLOOD HAS A VERY LIMITED TIME FOR USE. OBI ADMINISTERS FIVE LAYERS OF SAFETY PROCEDURES - BLOOD DONOR ELIGIBILITY STANDARDS, INDIVIDUAL SCREENING, LABORATORY TESTING, CONFIDENTIAL EXCLUSION OF DONATIONS AND DONOR RECORD CHECKS. EXTENSIVE COMPLIANCE AND TECHNICAL TENURE ARE REQUIRED TO GET BLOOD FROM A DONOR TO A PATIENT. BLOOD CENTERS ALSO WORK CLOSELY WITH GOVERNMENT AGENCIES AND OTHER ENTITIES ON QUALITY CONTROL AND TRACKING. AN ENTIRE TEAM MANAGES THE SUPPLY LOGISTICS WITH EVERY MEDICAL FACILITY SERVED SO THAT THEY HAVE THE RIGHT BLOOD AT THE RIGHT TIME FOR PATIENTS. THIS CAN FLUCTUATE GREATLY, EVEN WITHIN A FEW HOURS. COURIERS TRAVEL MORE THAN SIX MILLION MILES EACH YEAR TO TRANSPORT DONATED BLOOD TO CENTRAL LABS AND HOSPITALS WITH ACCURACY AND EFFICIENCY, LEAVING NO NEED UNMET, REGARDLESS OF THE SITUATION OR TRAVEL CONDITIONS. HOSPITALS AND PATIENTS ARE NOT CHARGED FOR THE DONATED BLOOD ITSELF. EXPENSES ARE RECOVERED THROUGH A SERVICE FEE FOR EMPLOYEE WAGES, FUEL, VEHICLES, ADVANCED TESTING EQUIPMENT AND BLOOD PROCESSING AS SUMMARIZED ABOVE. OBI'S FEES AND QUALITY HAVE MADE IT THE CHOSEN, SOLE SUPPLIER FOR MORE THAN 90 PERCENT OF OKLAHOMA'S BLOOD SUPPLY, AS WELL AS MORE THAN 40 ARKANSAS HOSPITALS, EIGHT HOSPITALS IN THE TEXOMA REGION AND MOST HOSPITALS IN THE TEXAS HIGH PLAINS REGION. IT REQUIRES 24/7, 365 DAYS-A-YEAR STAFFING AND OPERATIONS, MUCH LIKE AREA HOSPITALS.
TESTING SERVICES: WHILE MANY BLOOD CENTERS OUTSOURCE THEIR TESTING, OBI MAINTAINS AN IN-HOUSE TESTING LABORATORY TO PROVIDE A RAPID RESPONSE TO PROCESSING UNITS. WITH EVERY DONATION, OUR DILIGENT LABORATORY STAFF PERFORMS MULTIPLE TESTS TO ENSURE BLOOD PRODUCTS ARE SAFE AND READY TO BE TRANSFUSED TO LOCAL PATIENTS. AS A FULLY LICENSED AND CERTIFIED LABORATORY, OBI MAINTAINS THE HIGHEST STANDARDS AND LEADS THE NATION IN APPLYING CUTTING-EDGE TECHNOLOGY TO CREATE THE SAFEST BLOOD PRODUCTS POSSIBLE. OBI'S TESTING LABORATORY PROVIDES A WIDE SCOPE OF SAFETY TESTING FOR SEVERAL BLOOD-BORN CONDITIONS, LIKE HIV, HEPATITIS C, AND WEST NILE VIRUS, TO ENSURE BLOOD PRODUCTS ARE OF THE HIGHEST QUALITY. IF ANY SAMPLE IS POSITIVE FOR THESE ISSUES, OUR STAFF WILL NOTIFY THE DONOR AND REFER THEM FOR ADDITIONAL TESTING AND TREATMENT. AFTER THE BLOOD SAMPLE HAS BEEN CLEARED, ADDITIONAL HEALTH SCREENING TESTING IS PERFORMED. FOR EXAMPLE, WE TEST THE CHOLESTEROL LEVEL OF EVERY DONOR AS PART OF OUR STANDARD DONATION PROCESS.
PATIENT CARE REVENUE: THERAPEUTIC APHERESIS SERVICES FOR PATIENTS AT AREA HOSPITALS ARE PROVIDED BY SPECIALLY TRAINED REGISTERED NURSES UNDER THE DIRECTION OF TRANSFUSION MEDICINE PHYSICIANS. PATIENTS UNDERGO TREATMENTS THAT REMOVE HARMFUL PROTEINS, CHEMICALS OR CELLS IN THE BLOOD THAT CONTRIBUTE TO A VARIETY OF LIFE-THREATENING DISEASES OR TRANSPLANT COMPLICATIONS. BASED ON PATIENTS' CONDITIONS, SPECIFIC OFFENDING AGENTS OR COMPONENTS OF THE BLOOD ARE ISOLATED AND IRRADIATED OR REMOVED. AFTER THIS INTRICATE PROCESSING, PATIENTS RECEIVE THEIR TREATED BLOOD TO RESTORE HEALTH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
John B Armitage MD President & CEO | OfficerTrustee | 50 | $762,881 |
John Adams Board Member Until 9/2022 | Trustee | 2 | $2,500 |
Frank Barnett MD Board Member | Trustee | 1 | $0 |
Richard Boatsman MD Board Chair | OfficerTrustee | 3 | $0 |
Larry Bookman MD Board Member | Trustee | 3 | $16,620 |
Scott Calhoon MD Board Member | Trustee | 2 | $1,500 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
United Mechanical Facility Maintenance | 3/30/23 | $485,543 |
Caston Construction Construction Contractor | 3/30/23 | $1,292,953 |
Standley Systems Copier Rental/service | 3/30/23 | $344,077 |
Blue Cross And Blue Shield Of Oklahoma Benefits Administration | 3/30/23 | $1,502,020 |
Henson Construction Co Construction Contractor | 3/30/23 | $1,583,084 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $1,199,773 |
Investment income | $35,293 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $83,577 |
Net Gain/Loss on Asset Sales | $117,206 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $144,930,726 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $3,542,070 |
Compensation to disqualified persons | $52,034 |
Other salaries and wages | $47,654,872 |
Pension plan accruals and contributions | $1,524,036 |
Other employee benefits | $3,744,143 |
Payroll taxes | $4,467,883 |
Fees for services: Management | $0 |
Fees for services: Legal | $243,297 |
Fees for services: Accounting | $119,476 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $11,907 |
Fees for services: Other | $1,445,618 |
Advertising and promotion | $944,075 |
Office expenses | $689,926 |
Information technology | $1,344,079 |
Royalties | $0 |
Occupancy | $3,848,885 |
Travel | $274,024 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $73,610 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $5,252,220 |
Insurance | $352,509 |
All other expenses | $0 |
Total functional expenses | $123,847,115 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,967 |
Savings and temporary cash investments | $23,168,852 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $22,881,186 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $605,481 |
Inventories for sale or use | $5,770,489 |
Prepaid expenses and deferred charges | $1,194,207 |
Investments—publicly traded securities | $2,671,564 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $990,816 |
Other assets | $7,827,225 |
Total assets | $95,667,966 |
Accounts payable and accrued expenses | $15,377,270 |
Grants payable | $19,620 |
Deferred revenue | $2,123,214 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $6,963,716 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $24,483,820 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Total liabilities and net assets/fund balances | $71,184,146 |
Over the last fiscal year, Oklahoma Blood Institute has awarded $92,974 in support to 5 organizations.
Grant Recipient | Amount |
---|---|
GLOBAL BLOOD FUND PURPOSE: GLOBAL BLOOD FUND: THIS CHARITY (OF WHICH OBI IS THE SOLE MEMBER) HAS A MISSION TO IMPROVE TRANSFUSION CARE IN THE DEVELOPING WORLD. THIS IS CONSIDERED A NATURAL EXTENSION OF OBI'S PURPOSE TO SAVE PATIENT LIVES THROUGH BLOOD PRODUCTS PROVIDED IN OUR LOCAL SETTINGS. DONATIONS PROVIDED ARE THE RESULT OF BLOOD DONORS CHOOSING TO FORGO RECEIVING A T-SHIT AFTER COMPLETING A DONATION AND ARE MADE AT A RATE LESS THAN THE COST OF THE T-SHIRT. | $60,224 |
OKLAHOMA BIOSCIENCE PURPOSE: OKBIO PROMOTES THE GROWTH OF BIOSCIENCES AND LIFE SCIENCES IN OKLAHOMA THROUGH PARTNERSHIP BUILDING, EDUCATION AND OUTREACH, NETWORKING, POLICY DEVELOPMENT AND PUBLICITY. | $6,000 |
TULSA'S FUTURE INC PURPOSE: THE MISSION IS TO SUPPORT THE TULSA REGIONAL CHAMBER OF COMMERCE IN LESSENING THE BURDENS OF THE MUNICIPAL GOVEEMENT OF THE CITY OF TULSA AS THE CITY ENDEVORS TO IMROVE ECONOMIC GROWTH IN THE TULSA METRO AREA. | $10,000 |
OKLAHOMA COUNTY MEDICAL SOCITY PURPOSE: PROMOTE MEDICAL SCIENCE IN OKLAHOMA COUNTY. | $10,000 |
UNITED WAY OF CENTRAL OKLAHOMA PURPOSE: THIS CHARITY IS COMMITTED TO IMPROVING THE HEALTH, SAFETY, EDUCATION, AND ECONOMIC WELL-BEING OF INDIVIDUALS AND FAMILIES IN NEED IN CENTRAL OKLAHOMA BY CONNECTING COMMUNITY RESOURCES WITH RESPONSIVE AND ACCOUNTABLE HEALTH AND HUMAN SERVICES AGENCIES. OBI PROVIDED FUNDS TO HELP FURTHER THIS MISSION IN OUR LOCAL AREA. | $6,750 |